Antimalarial drug artemisinin moves into production
Monday, July 12, 2010 - 09:28
in Mathematics & Economics
(PhysOrg.com) -- A semi-synthetic version of the antimalarial drug artemisinin developed by UC Berkeley's Jay Keasling is moving out of development into full-scale production, helped along by a $10.7 million grant from the Bill & Melinda Gates Foundation to the Institute for One World Health. The drug, produced by genetically engineered bacteria, is much cheaper than the plant-derived drug available today.